आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

cipla (eu) limited - bivalirudin - pdr/conc/soln/inj/inf - 250 milligram - direct thrombin inhibitors

यूरोपीय संघ - अंग्रेज़ी - EMA (European Medicines Agency)

the medicines company uk ltd - bivalirudin - acute coronary syndrome - antithrombotic agents - angiox is indicated as an anticoagulant in adult patients undergoing percutaneous coronary intervention (pci), including patients with st-segment-elevation myocardial infarction (stemi) undergoing primary pci.angiox is also indicated for the treatment of adult patients with unstable angina / non-st-segment-elevation myocardial infarction (ua / nstemi) planned for urgent or early intervention.angiox should be administered with aspirin and clopidogrel.

यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

the medicines company uk ltd - bivalirudin - powder for solution for infusion - 250mg

यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - bivalirudin - powder for solution for infusion - 250mg

कनाडा - अंग्रेज़ी - Health Canada

sandoz canada incorporated - bivalirudin - powder for solution - 250mg - bivalirudin 250mg - direct thrombin inhibitors

कनाडा - अंग्रेज़ी - Health Canada

sandoz canada incorporated - bivalirudin - powder for solution - 250mg - bivalirudin 250mg - direct thrombin inhibitors

कनाडा - अंग्रेज़ी - Health Canada

fresenius kabi canada ltd - bivalirudin - powder for solution - 250mg - bivalirudin 250mg - direct thrombin inhibitors

यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

reig jofre uk ltd - bivalirudin - powder for solution for infusion - 250mg

बेल्जियम - अंग्रेज़ी - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - bivalirudin 250 mg - powder for concentrate for solution for injection/infusion - 250 mg - bivalirudin 250 mg - bivalirudin

सऊदी अरब - अंग्रेज़ी - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

the medicines company - bivalirudin - powder for concentrate for solution for infusion - 250 mg